Nucleonics Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

HORSHAM, Pa.--(BUSINESS WIRE)--Nucleonics, Inc., a privately held biotechnology company focused on the development of novel RNA interference-based therapeutics, announced today that Robert Towarnicki, President and CEO, will present a company overview at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The presentation will take place at 9:50 am on November 5, 2007, at the New York Palace Hotel in New York City.